Insmed Incorporated (INSM) — Fair Value Analysis

Base-case fair value (P50): $117.42 · Current price: $118.54 · Verdict: Fairly Valued

The Verdict on INSM

Based on our Monte Carlo simulations, Insmed Inc (INSM) is currently Fairly Valued. The median fair value (P50) generated by our models stands at $117.42, which indicates a marginal -0.9% against the current market price of $118.54. This narrow band suggests that the market's current valuation of INSM closely aligns with the most probable outcome derived from thousands of forward-looking scenarios. Investors seeking significant discrepancies between market price and intrinsic value may find INSM's present positioning less compelling, as its $118.54 is largely consistent with our median fair value projection.

How INSM stacks up against peers

While INSM appears fairly valued on a P50 basis, its operational and financial health quality tier is rated as weak relative to its sector. This classification flags potential vulnerabilities or challenges that could impact the company's performance, even if the current $118.54 is near our $117.42 estimate. A weak quality tier suggests that INSM may face greater headwinds or exhibit less resilience compared to its peers. This factor introduces a layer of risk for investors, where even a seemingly fair valuation could mask underlying operational pressures that might lead to greater volatility in both upside and downside scenarios around the current $118.54.

What this means for investors

For investors considering INSM, the "Fairly Valued" verdict from our Monte Carlo simulations, showing $118.54 to be close to $117.42 with -0.9%, suggests a balanced risk-reward profile at first glance. However, the weak quality tier is a critical consideration, implying that INSM may be more susceptible to adverse market conditions or operational missteps. While the median outlook is stable, the distribution of potential outcomes from our Monte Carlo analysis would offer a deeper understanding of the full bear-case and bull-case scenarios, which are not captured by the P50 alone. To access the complete distribution, track INSM's fair value as new fundamentals are released, and understand the probability of various price outcomes, sign up for a free FairCurve account.